0      0

Challenges and Opportunities in the Manufacturing of New Treatment Modalities

Jun 1, 2020 9:00am ‐ Jun 1, 2020 10:30am

Credits: None available.


  • Wilson W. Bryan, M.D., Director, Office of Tissues and Advanced Therapies, CBER/FDA
  • Joseph Famulare, Conference Chair, VP Global Compliance & External Collaboration, Genentech, A Member of the Roche Group
  • Eric Felz, Associate Director Validation, Takeda Pharmaceutical Company
  • Tim Howard, PE, CPIP, Interim CEO & President, ISPE
  • Carol Lynch, President, Head-North America, Sandoz US


Credits: None available.

You must be logged in and own this session in order to post comments.